Literature DB >> 26940507

Protein Partners of α-Synuclein in Health and Disease.

Louise Berkhoudt Lassen1, Lasse Reimer1, Nelson Ferreira1, Cristine Betzer1, Poul Henning Jensen1.   

Abstract

α-synuclein is normally situated in the nerve terminal but it accumulates and aggregates in axons and cell bodies in synucleinopathies such as Parkinson's disease. The conformational changes occurring during α-synucleins aggregation process affects its interactions with other proteins and its subcellular localization. This review focuses on interaction partners of α-synuclein within different compartments of the cell with a focus on those preferentially binding aggregated α-synuclein. The aggregation state of α-synuclein also affects its catabolism and we hypothesize impaired macroautophagy is involved neuronal excretion of α-synuclein species responsible for the prion-like spreading of α-synuclein pathology.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  Lewy Body; Parkinson's disease; dementia; neurodegeneration; protein interaction; proteomics; α-synuclein

Mesh:

Substances:

Year:  2016        PMID: 26940507     DOI: 10.1111/bpa.12374

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  17 in total

1.  Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.

Authors:  Istvan Horvath; Pernilla Wittung-Stafshede
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

2.  Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson's disease.

Authors:  Małgorzata Pokrzywa; Katarzyna Pawełek; Weronika Elżbieta Kucia; Szymon Sarbak; Erik Chorell; Fredrik Almqvist; Pernilla Wittung-Stafshede
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

3.  Interplay between tau and α-synuclein liquid-liquid phase separation.

Authors:  Anna Siegert; Marija Rankovic; Filippo Favretto; Tina Ukmar-Godec; Timo Strohäker; Stefan Becker; Markus Zweckstetter
Journal:  Protein Sci       Date:  2021-01-28       Impact factor: 6.725

4.  Differential Aggregation and Phosphorylation of Alpha Synuclein in Membrane Compartments Associated With Parkinson Disease.

Authors:  Ana Canerina-Amaro; Daniel Pereda; Mario Diaz; Deiene Rodriguez-Barreto; Verónica Casañas-Sánchez; Marija Heffer; Paula Garcia-Esparcia; Isidro Ferrer; Ricardo Puertas-Avendaño; Raquel Marin
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

5.  Abundant fish protein inhibits α-synuclein amyloid formation.

Authors:  Tony Werner; Ranjeet Kumar; Istvan Horvath; Nathalie Scheers; Pernilla Wittung-Stafshede
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

6.  ELISA method to detect α-synuclein oligomers in cell and animal models.

Authors:  Louise Berkhoudt Lassen; Emil Gregersen; Anne Kathrine Isager; Cristine Betzer; Rikke Hahn Kofoed; Poul Henning Jensen
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

7.  Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric α-synuclein.

Authors:  Jonas K Hannestad; Sandra Rocha; Björn Agnarsson; Vladimir P Zhdanov; Pernilla Wittung-Stafshede; Fredrik Höök
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

Review 8.  Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.

Authors:  Tony Werner; Istvan Horvath; Pernilla Wittung-Stafshede
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  Alpha-Synuclein Modulates the Physical Properties of DNA.

Authors:  Kai Jiang; Sandra Rocha; Alvina Westling; Sriram Kesarimangalam; Kevin D Dorfman; Pernilla Wittung-Stafshede; Fredrik Westerlund
Journal:  Chemistry       Date:  2018-09-19       Impact factor: 5.236

10.  Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T.

Authors:  Anna I Sulatskaya; Natalia P Rodina; Maksim I Sulatsky; Olga I Povarova; Iuliia A Antifeeva; Irina M Kuznetsova; Konstantin K Turoverov
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.